Limba
|
Bozitinib is a highly selective ATP-competitive c-Metinhibitor with blood-brain barrier permeability. Bozitinib (PLB-1001) selectively inhibits MET-altered tumor cells in preclinical models.
Price | 2.125,00 RON (preturile sunt fara TVA) |
---|---|
Description |
Bozitinib is a highly selective ATP-competitive c-Metinhibitor with blood-brain barrier permeability. Bozitinib (PLB-1001) selectively inhibits MET-altered tumor cells in preclinical models. |